Cargando…

HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients

A proportion of classical Hodgkin lymphomas harbor the Epstein Barr virus (EBV). We previously demonstrated that associations between Human Leukocyte Antigen (HLA) alleles and susceptibility to EBV+ classical Hodgkin lymphoma differ between European and Chinese populations. Data on Hispanic populati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fletcher, Luke B., Veenstra, Rianne N., Loo, Eric Y., Hwang, Amie E., Siddiqi, Imran N., Visser, Lydia, Hepkema, Bouke G., Nolte, Ilja M., van den Berg, Anke, Cozen, Wendy, Diepstra, Arjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363938/ https://www.ncbi.nlm.nih.gov/pubmed/28334025 http://dx.doi.org/10.1371/journal.pone.0174457

Ejemplares similares

HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters
por: Huang, Xin, et al.
Publicado: (2012)

HLA-A*02:07 Is a Protective Allele for EBV Negative and a Susceptibility Allele for EBV Positive Classical Hodgkin Lymphoma in China
por: Huang, Xin, et al.
Publicado: (2012)

HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
por: Tan, Geok Wee, et al.
Publicado: (2021)

Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma Development
por: Jiang, Peijia, et al.
Publicado: (2021)

PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV+ Hodgkin Lymphoma
por: Liu, Yuxuan, et al.
Publicado: (2013)

Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients
por: Huang, Xin, et al.
Publicado: (2010)

Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma
por: Jiang, Peijia, et al.
Publicado: (2022)

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China
por: Huang, Xin, et al.
Publicado: (2011)

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
por: Nijland, Marcel, et al.
Publicado: (2017)

The impact of HLA class I and EBV latency‐II antigen‐specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
por: Jones, K., et al.
Publicado: (2015)

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
por: Diepstra, Arjan, et al.
Publicado: (2022)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

Modeling HLA associations with EBV‐positive and ‐negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis
por: Johnson, Paul C.D., et al.
Publicado: (2015)

The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression
por: Habets, Thomas H. P. M., et al.
Publicado: (2018)

Antigen and Cell-Based Assays for the Detection of Non-HLA Antibodies
por: Lammerts, Rosa G. M., et al.
Publicado: (2022)

Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma
por: Visser, Lydia, et al.
Publicado: (2016)

HLA alleles modulate EBV viral load in multiple sclerosis
por: Agostini, Simone, et al.
Publicado: (2018)

CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma
por: Sattarzadeh, Ahmad, et al.
Publicado: (2015)

EBV protection‐ and susceptibility‐related HLA alleles and EBV status in the Chinese population: A single‐center study
por: Suolitiken, Dina, et al.
Publicado: (2022)

Erratum: Lydia Visser et al. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma, Int. J. Mol. Sci. 2016, 17, 2127
por: Sattarzadeh, Ahmad, et al.
Publicado: (2018)

Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2021)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma
por: Liang, Zheng, et al.
Publicado: (2014)

HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
por: Vietzen, Hannes, et al.
Publicado: (2023)

HLA-G Expression and Role in Advanced-Stage Classical Hodgkin Lymphoma
por: Caocci, G., et al.
Publicado: (2016)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
por: Trinh, Cua Thi Hong, et al.
Publicado: (2023)

T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation
por: Peereboom, Emma T. M., et al.
Publicado: (2021)

Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma
por: Langendonk, Myra, et al.
Publicado: (2022)

Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

The Association of HLA-Class I and Class II with Hodgkin's Lymphoma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma
por: De Re, Valli, et al.
Publicado: (2017)

Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors
por: Sooda, Anuradha, et al.
Publicado: (2022)

Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice
por: Dasari, Vijayendra, et al.
Publicado: (2023)

Personalized HLA typing leads to the discovery of novel HLA alleles and tumor‐specific HLA variants
por: Anzar, Irantzu, et al.
Publicado: (2022)

HLA-H: Transcriptional Activity and HLA-E Mobilization
por: Jordier, François, et al.
Publicado: (2020)

CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2022)

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants
Publicado: (1985)

HLA and nasopharyngeal carcinoma in Malays.
por: Chan, S. H., et al.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_cbmhkhbtqgdd3njflt2r710njt